Leor Sapir is a fellow at the Manhattan Institute focusing on Gender in American policy at the state and federal level. In this calmvo we discuss how special interests groups interact with the courts to shape public values, and how the gender issue won't be solved without serious longterm strategy. Follow Leor at https://twitter.com/LeorSapir Find Leor at https://manhattan.institute/person/leor-sapir Support this channel:  https://www.paypal.me/benjaminboyce https://cash.app/$benjaminaboyce https://www.buymeacoffee.com/benjaminaboyce

Leor Sapir, an expert in gender-affirming care, joins Sasha and Stella to discuss the consumerism of gender-affirming care, bans on gender-affirming care in the US, fostering of narcissism, and parallels with the recovered memory craze from the 1990s.

Leor Sapir, a writer and researcher at the Manhattan Institute and frequent contributor to City Journal, discusses topics such as the sudden increase in girls seeking transition, the medicalization of trans kids impacting their future orgasms, childhood experiences living on a kibbutz in Israel, serving in the IDF, the Dutch protocol for transing gender-dysphoric kids, and the shifting rhetoric surrounding gender identity.

Join Leor Sapir, a Fellow at the Manhattan Institute and a keen critic of trans ideology, as he dissects the current state of gender medicine. Discover how Trump's executive order may signal the decline of federal support for pediatric gender transition efforts. Sapir navigates the historical context and ethical concerns shaping today’s healthcare policies. He critiques fundamental research in gender medicine and addresses ongoing controversies, emphasizing the need for accountability and the shifting political landscape.

Leor Sapir, a fellow at the Manhattan Institute specializing in pediatric gender medicine, discusses the growing opposition to medical procedures for youth. He examines the historical context of gender ideology and its legal implications. The conversation delves into the controversial Cass Review, highlighting shaky evidence for current practices. Sapir also navigates pivotal lawsuits that could reshape treatment age restrictions and critiques both media narratives and institutional biases. The need for rigorous scientific inquiry in the debate over gender medicine takes center stage.